Read the latest news about I3P and the incubated startups.
The National Award GiovedìScienza is back in its 11th edition
The Award aims to highlight the activities of scientists and researchers who contribute to development and innovation. Nominations are open until 28/02/2022.
Leasys and I3P launch the new edition of "Digital Factory": Open Innovation for the mobility of the future
Participation in the call is open to young, innovative Italian and international companies, and is free of charge: proposals can be submitted until February 25, 2022.
StepToStart 2022: registrations are open for the new lectures cycle
The second edition of the StepToStart initiative is about to launch: registrations will be open until January 15, 2022.
Easyrain announced a new 5 million euros capital increase
EasyRain presented the new investment by Indaco Venture Partners SGR and Progress Tech Transfer in its aquaplaning technology solutions.
PNI 2021: the innovative startups Algor, Pixies and Reefilla win prizes
Algor, Pixies, and Reefilla are the three startups belonging to the I3P network that have been awarded at the final of the National Award for Innovation 2021.
Artificial intelligence for human learning: a year of achievements for the young start-up Algor
The project, started in January 2021 by a group of students, has already won major awards and aims to change the world of educational technology.
Space economy: the ESA BIC Turin opens the call to support space related startups
Generated from the synergy between I3P, Politecnico di Torino and Links Foundation, ESA Business Incubation Centre Turin is the new incubator supported by ESA and ASI.
Start Cup Piemonte Valle d'Aosta 2021: Elemento's new ethical and neutral cloud wins
Elemento Modular Cloud won first prize, Reefilla second and Fidelio Medical third. Ex aequo fourth place for Algor, Viper and Achilles.
Medme converts 930,000 euros of bonds in the capital of Biotechware, the cardiomonitor scaleup
Biotechware has closed yet another €930k investment round from Dutch company Medme BV.